4//SEC Filing
Vanda Pharmaceuticals Inc. 4
Accession 0001209191-15-035329
$VNDACIK 0001347178operating
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 4:21 PM ET
Size
8.5 KB
Accession
0001209191-15-035329
Insider Transaction Report
Form 4
Gibbs Thomas Edward
SVP, Chief Commercial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2015-04-20+175,000→ 175,000 totalExercise: $10.05Exp: 2025-04-19→ Common Stock (175,000 underlying) - Award
Restricted Stock Units
2015-04-20+60,000→ 60,000 total→ Common Stock (60,000 underlying)
Footnotes (4)
- [F1]This option vests and becomes exercisable with respect to 1/4 of the shares subject to this option on April 20, 2016 (the "Initial Vesting Date"), provided Reporting Person remains continously employed by the Issuer through the Initial Vesting Date, and with respect to the remaining 3/4 of the shares in 36 equal monthly installments beginning on May 20, 2016, provided Reporting Person remains continously employed by the Issuer through each monthly vesting date.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive a share of the Issuer's common stock.
- [F3]The RSUs shall vest in four (4) equal annual installments beginning January 1, 2016, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissable Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
- [F4]Not applicable.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001347178
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 4:21 PM ET
- Size
- 8.5 KB